✦ LIBER ✦

High-dose therapy with autologous hematopoietic cell support as salvage treatment for patients with breast cancer who have relapsed after previous high-dose chemotherapy

✍ Scribed by Bearman, S I; Vredenburgh, J J; Cagnoni, P J; Shpall, E J; Nieto, Y; Ross, M; Peters, W P; Jones, R B

Book ID: 110012175
Publisher: Nature Publishing Group
Year: 1999
Tongue: English
Weight: 42 KB
Volume: 24
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1701937

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early salvage therapy for germ cell canc

Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support

✍ E. Randolph Broun; Craig R. Nichols; Martine Turns; Stephen D. Williams; Patrick 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 530 KB

Background. Patients with relapsed germ cell cancer (GCT) have a poor prognosis when treated solely with conventional chemotherapy; high dose chemotherapy with autologous bone marrow rescue (ABMR) has shown curative potential in patients with relapsed and refractory GCT. This protocol was designed t

High dose chemotherapy with autologous s

High dose chemotherapy with autologous stem cell support for the treatment of metastatic breast cancer

✍ Lois J. Ayash 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB 👁 1 views

Use of Capecitabine as First-Line Therap

Use of Capecitabine as First-Line Therapy in Patients with Metastatic Breast Cancer Relapsing After High- Dose Chemotherapy and Autologous Stem Cell Support

✍ A. Bashey; S. Sundaram; S. Corringham; V. Jones; D. Lancaster; J. Silva-Gietzen; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Stem Cell Dose and Tumorbiologic Paramet

Stem Cell Dose and Tumorbiologic Parameters as Prognostic Markers for Patients with Metastatic Breast Cancer Undergoing High-Dose Chemotherapy with Autologous Blood Stem Cell Support

✍ Manfred Hensel; Andreas Schneeweiss; Hans-Peter Sinn; Gerlinde Egerer; Martin Ko 📂 Article 📅 2002 🏛 AlphaMed Press 🌐 English ⚖ 121 KB

High-dose chemotherapy with autologous b

High-dose chemotherapy with autologous bone marrow support as consolidation after standard-dose adjuvant therapy in primary breast cancer patients with seven or more involved axillary lymph nodes

✍ Lalisang, R I; Hupperets, P S G J; ten Haaft, M A; Jansen, R L H; Schouten, H C 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 52 KB

Multiple cycles of high dose chemotherap

Multiple cycles of high dose chemotherapy supported by hematopoietic progenitor cells as treatment for patients with advanced malignancies

✍ Gwynn D. Long; Robert S. Negrin; Christine F. Hoyle; Claus R. Kusnierz-Glaz; Jef 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 910 KB